Recruiting studies: Direct Oral Anticoagulants Doacs

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism
NA · 1 location(s) · Scott C. Woller, MD · NCT06232551 Timing to Restart Direct Oral Anticoagulants After Traumatic Intracranial Haemorrhage
Phase 3 · 2 location(s) · Walton Centre NHS Foundation Trust · NCT06322953 The Direct Oral Anticoagulation Versus Vitamin K Antagonist After Cardiac Surgery Trial
Phase 3 · 19 location(s) · Population Health Research Institute · NCT04284839 Timing of Resumption of Direct Oral Anticoagulants Following Polypectomy
NA · 1 location(s) · The University of Hong Kong · NCT06482333 Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Direct Oral Anticoagulants Intake
Phase 4 · 14 location(s) · Insel Gruppe AG, University Hospital Bern · NCT06571149 Perioperative Anticoagulant Use for Surgery Evaluation -Virtual Visit (PAUSE-Virtual)
Phase N/A · 10 location(s) · McMaster University · NCT06844227 Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis
Phase 4 · 1 location(s) · Asian Institute Of Medical Sciences · NCT07521332 Cardiac Assessment for Recurrent Stroke Risk Evaluation in Atrial Fibrillation
Phase N/A · 1 location(s) · Insel Gruppe AG, University Hospital Bern · NCT06954610 Direct Oral Anticoagulants for the Treatment of Cerebral Venous Thrombosis
Phase N/A · 1 location(s) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT04660747 Cohort of Patients With Left Ventricular Thrombus: Management and Outcomes in the Direct Oral Anticoagulants Era
Phase N/A · 1 location(s) · Insel Gruppe AG, University Hospital Bern · NCT05028777 The Study of Monitoring and Dosing Guidance of Direct Oral Anticoagulants Based on Pharmacokinetics, Pharmacodynamics, a
Phase N/A · 1 location(s) · Peking Union Medical College Hospital · NCT06362343 Risk Score of Embolism in Patients With AF Undergoing DOAC Therapy
Phase N/A · 2 location(s) · Hospital Universitari Vall d'Hebron Research Institute · NCT07713537 Hip Fracture Surgery Timing and Blood Transfusion Risk in Patients on DOACs
Phase N/A · 7 location(s) · St. Antonius Hospital · NCT07309848 International Registry of Thrombotic APS Patients Treated With Direct Oral Anticoagulants
Phase N/A · 1 location(s) · Stéphane Zuily · NCT04262492 Oral Biopsy Bleeding in Patients on Direct Oral Anticoagulants (DOACs)
Phase N/A · 1 location(s) · University of Pisa · NCT07520890 Intravenous Thrombolytic Therapy in Acute Ischemic Stroke Patients on DOAC
NA · 1 location(s) · Chinese University of Hong Kong · NCT06241677 Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants
Phase N/A · 33 location(s) · Insel Gruppe AG, University Hospital Bern · NCT06556446 Rivaroxaban in Elderly Chinese Venous Thromboembolism Patients
Phase N/A · 1 location(s) · Peking Union Medical College Hospital · NCT06194617 Observational Study to Evaluate the Effectiveness of DOACS for Secondary Thrombosis Prevention in Low-risk Thrombotic AP
Phase N/A · 2 location(s) · Infanta Leonor University Hospital · NCT07372170 Study Protocol: Impact of Metamizole (Optalgin®) on Anti-Xa Concentrations in Oncology Patients Receiving DOACs
NA · 1 location(s) · Rambam Health Care Campus · NCT07384013 What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI?
Phase 4 · 20 location(s) · St. Antonius Hospital · NCT04436978 Best Antithrombotic Therapy in Patients With Acute Venous ThromboEmbolism While Taking Antiplatelets
Phase 3 · 28 location(s) · Centre Hospitalier Universitaire de Saint Etienne · NCT05627375 RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing
Phase 3 · 37 location(s) · University Hospital, Angers · NCT06195540 A Trial on Prophylactic Clipping to Prevent Post-polypectomy Bleeding After Colonoscopy in Direct Oral Anticoagulant Use
NA · 1 location(s) · Chinese University of Hong Kong · NCT05169242 Advancing Knowledge in Ischemic Stroke Patients on Oral Anticoagulants
Phase N/A · 47 location(s) · University of L'Aquila · NCT06823466 Effect of Apiban Therapy on AVF Maturation in ESRD Patients
NA · 1 location(s) · Combined military hospital lahore · NCT07559942 DOAC in Chinese Patients With Atrial Fibrillation
Phase N/A · 1 location(s) · Chinese University of Hong Kong · NCT05378035 Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies
NA · 1 location(s) · Medical University of Gdansk · NCT07270263 NOAC Therapy Guided by PARIS Risk Score and D-dimer in Patients With ACS After PCI
Phase 4 · 1 location(s) · China National Center for Cardiovascular Diseases · NCT05638867 Thrombolysis in Factor Xa-inhibitors Trial
Phase 3 · 13 location(s) · Guri Hagberg · NCT06878066

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.